EDGAR Filing Documents for 0000000000-21-012493

Form UPLOAD - SEC-generated letter:

SEC Accession No. 0000000000-21-012493

Filing Date

2021-10-15

Accepted

2021-10-15 11:30:04

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.pdf	LETTER	27664
2		filename2.txt	TEXT-EXTRACT	1499
	Complete submission text file	0000000000-21-012493.txt		40301

Mailing Address 414 COMMERCE DRIVE STE 120 FORT WASHINGTON PA 19034

Business Address 25-28 NORTH WALL QUAY DUBLIN L2 D01 H104 (610) 816-6640

Nabriva Therapeutics plc (Filed for) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations